- Home
- LENZ vs DSL Comparison
LENZ vs DSL Comparison
Compare LENZ & DSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- DSL
- Stock Information
- Founded
- LENZ 2019
- DSL 2013
- Country
- LENZ United States
- DSL United States
- Employees
- LENZ N/A
- DSL N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- DSL Trusts Except Educational Religious and Charitable
- Sector
- LENZ Health Care
- DSL Finance
- Exchange
- LENZ Nasdaq
- DSL Nasdaq
- Market Cap
- LENZ 1.2B
- DSL 1.4B
- IPO Year
- LENZ 2021
- DSL N/A
- Fundamental
- Price
- LENZ $22.89
- DSL $11.53
- Analyst Decision
- LENZ Strong Buy
- DSL
- Analyst Count
- LENZ 4
- DSL 0
- Target Price
- LENZ $56.25
- DSL N/A
- AVG Volume (30 Days)
- LENZ 1.4M
- DSL 693.5K
- Earning Date
- LENZ 11-05-2025
- DSL 01-01-0001
- Dividend Yield
- LENZ N/A
- DSL 11.44%
- EPS Growth
- LENZ N/A
- DSL N/A
- EPS
- LENZ N/A
- DSL N/A
- Revenue
- LENZ $17,500,000.00
- DSL N/A
- Revenue This Year
- LENZ N/A
- DSL N/A
- Revenue Next Year
- LENZ $285.82
- DSL N/A
- P/E Ratio
- LENZ N/A
- DSL N/A
- Revenue Growth
- LENZ N/A
- DSL N/A
- 52 Week Low
- LENZ $16.54
- DSL $10.58
- 52 Week High
- LENZ $50.40
- DSL $13.00
- Technical
- Relative Strength Index (RSI)
- LENZ 24.51
- DSL 25.56
- Support Level
- LENZ $21.21
- DSL $11.42
- Resistance Level
- LENZ $32.00
- DSL $11.62
- Average True Range (ATR)
- LENZ 2.46
- DSL 0.12
- MACD
- LENZ -1.06
- DSL -0.01
- Stochastic Oscillator
- LENZ 10.47
- DSL 21.07
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About DSL DoubleLine Income Solutions Fund of Beneficial Interests
DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.